The mRNA levels of both CCL10 and TLR3 were significantly upregulated after the first and fourth DC vaccination, and CCL10 could guide CD8+ T cells into brain tumor sites,93 thus improving the inhibitory immune microenvironment in glioma patients.94 Here, CD8A is linked to central nervous system cancer.